Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Classement en actions #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Prix de l'action
$29.86
Dernière synchronisation: 2026-08-19
Capitalisation boursière
$2.48B
Changement (1 jour)
4.92%
Changement (1 an)
502.82%
Pays
TW
Échange Lin BioScience, Inc. (6696)

Catégorie

Historique du prix de l'action pour Lin BioScience, Inc. (6696)
Prix de clôture le plus élevé : $26.88 le 2026-08-01

Prix de clôture le plus bas : $1.30 le 2018-10-01
Historique du prix de l'action de Lin BioScience, Inc. de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$543.30 39.64%
US
$1.05K 47.66%
NL
$122.63 -12.65%
AU
$144.26 474.74%
US
$761.61 6.68%
CH